Last month, Bharat Biotech had announced that Covaxin would be assessed in the United States as a COVID-19 vaccine candidate.

"We are pleased to be able to move our clinical program for Covaxin forward, which we hope will bring us closer to offering an alternative ...

Covaxin has already been granted Emergency Use Listing (EUL) in 13 countries as on January 31 according to the WHO. Covaxin was granted EUL...

CEPI first partnered with IVI and Bharat Biotech in June 2020, providing up to USD 14.1 million for vaccine manufacturing and clinical deve...

In a written response to a question in the Rajya Sabha, Union Science and Technology Minister Jitendra Singh said Cadila Healthcare Ltd's D...

Efforts are being ramped up for massive production of COVID-19 vaccines and make them available in the shortest possible time, the DBT Secr...

Department of Biotechnology Secretary Renu Swarup said a financial support of Rs 400 crore is being provided to vaccine candidates from Zyd...

The companies have entered into a definitive agreement for Covaxin, an advanced stage whole-virion inactivated COVID-19 vaccine candidate, ...

COVAXIN has been developed by Bharat Biotech, a company based in Hyderabad, with backing from the state-run Indian Council of Medical Resea...

“The drug regulator is examining the application,” an official told ET, adding that the regulator is yet to fix the date for the subject ex...

As per the letter of intent (LOI), "Ocugen will have US rights to the vaccine candidate and, in collaboration with Bharat Biotech, will be ...

“India will have to focus on the indigenous vaccines and the AstraZeneca-Oxford vaccine. These vaccines are being tested in the India popul...

“We are planning to initiate a large phase 3 multicentre study to evaluate the efficacy and safety of the vaccine,” Bharat Biotech said in ...

“Human trial with Corona vaccine (COVAXIN) of Bharat Biotech started at PGI Rohtak today,” Vij, who is also the Home and Science & Technolo...

Bharat Biotech has got nod from the DCGI to begin human trials of the first indigenous Covid-19 vaccine.

The SARS-CoV-2 strain was isolated in NIV and transferred to Bharat Biotech, which has developed the indigenous, inactivated vaccine at its...

The vector used in this new COVID-19 vaccine under accelerated development program is a deactivated rabies vaccine that is known to produce...